Loading...
XTSE
JWEL
Market cap1.03bUSD
Dec 05, Last price  
34.03CAD
1D
-0.12%
1Q
-8.52%
IPO
94.46%
Name

Jamieson Wellness Inc

Chart & Performance

D1W1MN
XTSE:JWEL chart
P/E
27.42
P/S
1.94
EPS
1.24
Div Yield, %
1.73%
Shrs. gr., 5y
1.58%
Rev. gr., 5y
16.29%
Revenues
734m
+8.52%
193,218,000230,865,000248,331,000300,619,000319,776,000344,980,000403,661,000451,032,000547,369,000676,172,000733,780,000
Net income
52m
+8.42%
-33,176,000-95,382,000-25,166,000-23,787,00026,673,00031,657,00041,598,00052,082,00052,808,00047,882,00051,914,000
CFO
62m
+94.17%
9,847,00018,009,00029,009,00017,845,00027,805,00016,396,00040,596,00044,405,00050,589,00031,713,00061,578,000
Dividend
Aug 30, 20240.21 CAD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
IPO date
Jul 07, 2017
Employees
891
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT